Skip to main content
Medical information Clinical review pending

Genetic Testing

Beta Thalassemia-9 Common Mutations Screening Couple

Screening for both partners to identify common genetic mutations linked to Beta Thalassemia, a blood disorder. Helps couples understand risks before family planning.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Peripheral blood sample (EDTA tube). Confirm with the laboratory before booking.
Results
Confirm with the laboratory before booking.
Preparation
No specific preparation is required for this test. Confirm with the laboratory before booking.
Test priceKSh 15,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Beta Thalassemia-9 Common Mutations Screening Couple test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Couples planning pregnancy.
  • ✓Individuals with a family history of thalassemia or related blood disorders.
  • ✓Individuals of Mediterranean, African, or Asian descent.
  • ✓Couples seeking genetic risk assessment before conception.
02

In plain language

What this test helps you understand

Identifies carrier status for nine common Beta Thalassemia mutations in both partners, assessing the risk of passing the condition to offspring. Informs family planning decisions and guides potential prenatal testing options.
The Beta Thalassemia-9 Common Mutations Screening for couples is a genetic test designed to identify specific mutations associated with Beta Thalassemia. This screening is particularly important for couples planning to conceive, as it helps in assessing the risk of having children with thalassemia, a serious blood disorder that affects hemoglobin production. This test detects the presence of nine common mutations in the beta-globin gene. By analyzing a sample of peripheral blood, healthcare providers can determine whether one or both partners are carriers of these mutations. Understanding your genetic status can provide valuable insights for family planning and potential early intervention options.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific preparation is required for this test. Confirm with the laboratory before booking.
SamplePeripheral blood sample (EDTA tube). Confirm with the laboratory before booking.
MethodologyMolecular genetic testing (e.g., PCR, sequencing) to detect specific DNA sequence variations in the beta-globin gene. Confirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test screens for nine common mutations and may not detect all possible Beta Thalassemia mutations. A negative result does not completely rule out the possibility of being a carrier for less common mutations. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Beta Thalassemia is an inherited blood disorder where the body makes less hemoglobin than normal, leading to anemia.
Screening helps determine if both partners carry a mutation, which increases the risk of having a child with Beta Thalassemia.
A carrier has one copy of the mutated gene but usually does not have symptoms of the disorder. They can pass the gene to their children.
If both partners are carriers, there is a 25% chance with each pregnancy that the child will be affected by Beta Thalassemia. Genetic counseling can discuss options.
A doctor's prescription is generally required, but exceptions may apply. Please confirm with the laboratory.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp